View Article

Abstract

BACKGROUND: Drug utilization evaluation studies are critical in understanding patient prescription patterns, which help to improve the suitable and efficient use of antibiotics. Studies that evaluate drug use are crucial in determining patient prescription patterns, which aid in improving suitable and efficient use of antibiotics and creating the right guidelines for their use in hospitals. METHODOLOGY: A Prospective observational Study is planned to be conducted on 83 patients admitted to general medicine ward. The study individuals were selected using inclusion and exclusion criteria. Data was collected by evaluating treatment charts of the patients. At the conclusion of the investigation, the acquired data were meticulously compiled and statistically analyses. RESULTS: The study results show the prescribing pattern of antibiotics, where the class of antibiotics were found as 28% of Tetracycline, 18% of Fluroquinolone, 15% of Nitroimidazole, 49% of Cephalosporins, 24% of penicillin’s, 13% of Macrolide. The therapeutic outcomes were recorded in which 67% were cured, 26% was controlled and 6% patients show no improvement. CONCLUSION: The current investigation could evaluate antibiotic prescribing patterns, antibiotic therapeutic outcomes, and culture sensitivity patterns. In the study population, cephalosporins were most often administered antibiotics, followed by tetracyclines. According to the culture sensitivity pattern, streptococcus pneumonia, mycobacterium tuberculosis, and hepatitis A virus were the next most common bacteria found. According to statistical analysis, a patient's age will have an impact on their recovery. In these investigations, the vast majority of patients were healed.

Keywords

Antibiotics; Drug Utilization; Antibiotic Audit; Prescription; General Medicine

Introduction

For decades, antibiotics have been widely used around the world to treat a wide range of bacterial infections because they are strong and efficient medications that combat infectious diseases brought on by bacteria. Since they first came on the scene over fifty years ago, antibiotics have saved millions of lives(1).Antibiotics are drugs that treat bacterial illnesses. Viral infections are unaffected by antibiotics. In the beginning, an antibiotic was a chemical that one microbe created that specifically stopped another from growing. Since then, synthetic antibiotics that perform similar functions have been developed; these are typically chemically related to natural antibiotics.(2) The primary objective is to study the prescribing pattern of antibiotics. The secondary objective is to study the therapeutic outcomes of antibiotics(3).

Classification Of Antibacterial Agents:

Antibiotics can be classified based on chemical structure, bacterial spectrum and mode of action.  Antibiotics within the same structural class typically have equal toxicity, effectiveness, and allergy potential.  The most often used antibiotic classes include aminoglycosides, penicillins, fluoroquinolones, cephalosporins, macrolides, and tetracyclines.  Each pharmaceutical class has unique characteristics, even if it includes multiple drugs(3)

Classification by Chemical Structure:

  • Beta-Lactams
  • Tetracyclines
  • Fluoroquinolones
  • Macrolides
  • Sulfonamides
  • Aminoglycosides

Classification by Mode of Action: 

  • Bactericidal
  • Bacteriostatic

Classification by Spectrum of Activity:

  • Narrow-spectrum
  • Broad-spectrum

Drug Utilization Evaluation

The regulated, systematic, continuous review of patient medication use, pharmacist dispensing, and healthcare provider prescriptions is known as Drug Utilization Evaluation (DUE)(4). Drug use evaluations examine a patient's prescription and medication data before, throughout, and after treatment to ensure appropriate medication selection and positive patient outcomesand after dispensing(2). Drug therapy is regarded as a key element of patient care in primary healthcare and other healthcare settings. Even while patients benefit much from pharmaceutical therapies, it is impossible to ignore the dangers of medications and the repercussions of improper usage(5). The introduction of powerful medications with a higher risk of adverse drug reactions, the high cost of medication, and a focus on drug use outcomes and clinical misuse of drugs can all result in preventable patient morbidity and mortality, expensive remedial care, additional costs for the diagnosis and treatment of iatrogenic diseases, and unnecessary waste of health resources. Inadequate comprehension of treatment plans and diagnostic proficiency have resulted in poor medication selection, dosage, adverse drug reactions, drug interactions, and overuse of expensive medications when less expensive alternatives might be equally or more effective(2).Drug Utilization Evaluation, or DUE, has been suggested as a way to monitor, assess, and encourage sensible drug therapy in order to detect improper or needless drug use. Increased morbidity, mortality, and medical costs have been linked to a number of issues, including irrational drug usage, polypharmacy, improper drug selection, dosage, and interactions, as well as the use of medications without evidence of efficacy(6). Antibiotic abuse or inappropriate use results in major adverse drug responses, medication resistance, and higher healthcare costs(7). Drug utilization evaluation studies are crucial in determining patient prescription patterns, which aid in the development of appropriate hospital antibiotic usage protocols and the provision of valuable information for bettering the appropriate and efficient use of antibiotics(3). The goal of drug utilization evaluation is to determine the rationale of pharmacological treatment.Methods for auditing pharmacological therapy towards rationality are required to achieve this goal. Descriptive and analytical studies are the two categories of drug utilization evaluation. The former has focused on characterizing drug use patterns and identifying issues that warrant more thorough research(8).Analytical studies link medication use data to statistics on morbidity, treatment outcomes, and service quality to assess the effectiveness of pharmacological therapy(9).

2. MATERIALS AND METHOD:

A Prospective observational Study is planned to be conducted at MVJ Medical College and Research Hospital, Bangalore, South India.After receiving approval from the Institutional Ethical Committee, the study was carried out. Every patient who satisfied the requirements for inclusion was added to the trialto participate in the trial, patients must be at least 18 years old, male or female, admitted to the study site during the study period, and administered antibiotics.& exclusion criteria (those who refuse to participate in the trial and those for whom antibiotics are not provided are excluded). Information on the patient was gathered by looking up lab results, past medication histories, and other pertinent information. Data was gathered by looking at the patients' treatment records. When the study is over, the information gathered will be compiled systematically and will be subjected to statistical analysis. In this study statistical tools like ANOVA and Chi Square were used for the prescribing pattern of antibiotics and MX-excel was performed.

3. RESULTS:

Table 1: Classification By Gender

Sl No

Gender

No. Of Cases (N=83)

1.

Male

47

2.

Female

36

       
            Gender Distribution.png
       

Fig 1: Gender Distribution

According to the study's findings, 43% of the patients were female and 57% of the patients were male.

Table 2: Distribution By Age

SL NO

Age

No. of people prescribed (N=83)

1.

< 20

3

2.

20-40

29

3.

41-60

38

4.

61-80

12

5.

>80

1

       
            Age Wise Distribution.png
       

Fig 2: Age Wise Distribution

A review of the patients' age distribution found that 4% of prescriptions were written for patients under the age of 20, 35% for those aged 20 to 40, and 46% forpeople aged 41 to 60, 14% for people aged 61 to 80, and 1% for people above 80.

Table 3: Study Population of Comorbid Conditions

Disease Condition

No. of patients (N=83)

Gastro intestinal disorders

7

Diabetes mellitus

9

Viral Fevers

23

Respiratory disorders

16

Renal disorders

7

Liver disorders

5

Cardiovascular diseases

3

CNS disorders

2

Tuberculosis

2

Anemia

2

Hypertension

2

Urinary tract infection

5

       
            Study population of co morbid conditions.png
       

Fig 3: Study population of co morbid conditions

9% of patients had GID, followed by 11% with diabetes, 28% with viral fever, 20% with respiratory disorders, 9% with renal disorders, 6% with liver disorders, 3% with cardiovascular disorders, 2% with central nervous system disorders, 2% with tuberculosis, 2% with anemia, 2% with hypertension, and 6% with urinary tract infections, according to the study on the analysis of co-morbidities of the study population.

Table 4: Classes Of Prescription Antibiotics

SL NO

Antibiotics

No. of prescription (N=83)

1.

Fluroquinolone

15

2.

Tetracycline

24

3.

Nitroimidazole

13

4.

Cephalosporins

41

5.

Glycopeptides

1

6.

Macrolide

11

7.

pencillins

20

8.

Sulfonamides

1

9.

Lincosamide

2

10.

Glycylcyline

1

11.

Aminoglycoside

1

       
            Classes of Antibiotics prescribed.png
       

Fig 4: Classes of Antibiotics prescribed

According to the study, cephalosporins accounted for approximately 49% of the antibiotics prescribed to patients, with pencillins (24%), nitroimidazole (15%), fluoroquinolones (18%), and macrolide (13%) coming in second and third, respectively. Lincosamide (2%), sulfonamides (1%), aminoglycosides (1%), Glycylcyline (1%), Tetracyclins (28%), and glycopeptides antibiotics (1%).

Table 5: Total Number of Prescribed Antibiotics (N=83)

SL NO

No. of Antibiotics

No. of patients prescribed (N=83)

1.

1

41

2.

2

32

3.

3

7

4.

4

2

       
            Number of antibiotics prescribed.png
       

Fig 5: Number of antibiotics prescribed

Most patients were prescribed only one antibiotic throughout their hospital stay, with 41 receiving two, 32 receiving three, and two receiving four.

Table 6: Reason For Antibiotic Prescription (N=83)

SI. No.

Antibiotics

No. of patients prescribed

1.

Prophylaxis

13

2.

BPI

40

3.

Non- BPI

30

       
            Reason for Antibiotic Prescription.png
       

Fig 6: Reason for Antibiotic Prescription

The study found that 48% of patients received antibiotics for Bacteriologically Proven Infection (BPI), 36% for Non-BPI, and 16% for prophylaxis.

Table 7: Antibiotics Therapy Results

SI No.

Therapy outcomes

No. of patients prescribed

1.

Cured

56

2.

Controlled

22

3.

No improvement

5

       
            Antibiotic Therapy Results.png
       

Fig 7: Antibiotic Therapy Results

According to patient reports on the therapeutic effects of antibiotics, around 67% of patients experienced a full recovery from the treatment, 26% demonstrated a controlled response, and 7% exhibited no improvement at all.

Table 8: Therapeutic Outcomes According to The Age (N= 83)

Age

Therapeutic outcome

Therapeutic outcome

56

2

Controlled

45

1

Cured

71

2

Controlled

58

2

Controlled

35

2

Controlled

45

1

Cured

30

1

Cured

35

2

Controlled

48

1

Cured

54

2

Controlled

27

2

Controlled

23

1

Cured

30

2

Controlled

19

1

Cured

43

3

No improvement

45

1

Cured

65

1

Cured

50

1

Cured

42

3

No improvement

48

1

Cured

49

1

Cured

45

1

Cured

59

2

Controlled

65

1

Cured

66

3

No improvement

42

1

Cured

44

1

Cured

29

1

Cured

35

1

Cured

40

1

Cured

64

2

Controlled

50

1

Cured

23

1

Cured

69

2

Controlled

56

3

No improvement

31

1

Cured

48

1

Cured

19

1

Cured

49

1

Cured

56

2

Controlled

23

1

Cured

58

1

Cured

66

2

Controlled

35

1

Cured

31

1

Cured

38

1

Cured

21

1

Cured

54

2

Controlled

34

1

Cured

55

2

Controlled

35

1

Cured

19

1

Cured

39

1

Cured

65

2

Controlled

64

3

No improvement

31

1

Cured

54

1

Cured

70

2

Controlled

56

1

Cured

47

2

Controlled

29

1

Cured

46

1

Cured

83

1

Cured

42

2

Controlled

31

1

Cured

35

1

Cured

34

1

Cured

34

2

Controlled

59

1

Cured

48

1

Cured

38

1

Cured

61

1

Cured

47

1

Cured

48

2

Controlled

31

1

Cured

58

1

Cured

53

1

Cured

72

1

Cured

38

1

Cured

28

1

Cured

56

1

Cured

43

1

Cured

46

2

Controlled

Table 8A: Therapeutics Outcomes According to The Age

Anova: Single Factor

           

SUMMARY

           

Groups

Count

Sum

Average

Variance

   

Age

83

3763

45.33735

206.9092

   

Therapeutic outcome no

83

115

1.385542

0.36174

   

ANOVA

           

Source of Variation

SS

df

MS

F

P-value

Significance F

Between Groups

80168.1

1

80168.1

773.5585

5.6

3.89

Within Groups

16996.22

164

103.6355

     
             

Total

97164.31

165

       

After the statistical study was completed, the following findings were observed: Every group shares the same continuous variable mean. H1: At least one group has a different continuous variable mean. Therefore, age has an impact on patients' ability to recuperate.

Table 9: Factors Affecting Number of Antibiotics Prescribed (N=83)

No. of Antibiotics

 

 

N

1

Antibiotic

2

Antibiotics

3

Antibiotics

Gender

Male

Female

47

36

24

18

19

14

4

4

Age

<20

21-40

41-60

61-80

>80

3

29

38

12

1

2

12

18

6

1

1

14

16

4

3

4

2

Stay Period

<5 days

5 days

>5 days

36

27

17

25

11

10

15

10

5

6

6

2

       
            Gender factor affecting the number of antibiotics prescribed.png
       

Fig 9A: Gender factor affecting the number of antibiotics prescribed

       
            Age factor affecting the No. of Antibiotics prescribed.png
       

Fig 9B: Age factor affecting the No. of Antibiotics prescribed

       
            Stay period affecting the No. of Antibiotics prescribed.png
       

Fig 9C: Stay period affecting the No. of Antibiotics prescribed

The study linked the amount of antibiotics prescribed to gender, age, and duration of therapy, and it was shown that the majority of patients were prescribed only one antibiotic. In terms of gender, 24 males and just 18 females were administered single antibiotics. Compared to other age groups, the majority of patients aged 21-40 and 41-60 were prescribed a single antibiotic during the research.

Table 10: Organisms Isolated

SL NO

Organisms

No. of patients

1.

Streptococcus pneumonia

5

2.

E. coli

6

3.

Hepatitis A virus

1

4.

Mycobacterium tuberculosis

2

       
            Organism Isolated.png
       

Fig 10: Organism Isolated

The study presents many strains of organisms identified from the patient's culture test. Streptococcus pneumoniae was the most prevalent isolated organism, accounting for 35%, followed by E.coli 42%, Hepatitis A virus 7%, and Mycobacterium tuberculosis 14%.

Table 11: Culture Sensitivity Specimen

SL NO

Specimen

No. of patients

1.

Sputum

7

2.

Urine

6

3.

Blood

1

       
            Culture Sensitivity Specimen.png
       

Fig 11: Culture Sensitivity Specimen

The specimens used in the culture sensitivity test were sputum (43%), urine (7%), and blood (50%).

4. DICUSSION:

The current study on gender categorization found that men made up the majority of the study population.A comparable study by Ravi Pathiyil Shankar et al. (2003) discovered that the majority of patients were men. An examination of the age distribution found that the bulk of prescriptions were written for those between the ages of 21 and 40, followed by those aged 41 to 60.Mujtaba Hussain et al. (2014) observed that the majority of prescriptions were for people aged 46 to 60. In the current study, categorization based on co morbid illnesses was examined, and it was discovered that the majority of patients had viral fever, which was consistent with a study conducted by Mohanraj Rathinavelu et al (2015), who stated that the majority of patients had urinary tract infection(3). Cephalosporins and tetracyclines were the two most commonly prescribed antibiotics to patients, according to the current study. This study was similar to one conducted by Venu Gopal D et al. (2014), who discovered that cephalosporins were predominantly prescribed to inpatients and penicillin usage was highest in outpatients. Ceftriaxone (24.6%) and piperacillin/tazobactum (40.6%) were the most often provided antibiotics during hospitalization, according to a comparable study by Meher B. R. et al. (2014). In line with a study by R Selvaraj et al. (2015), the majority of prescriptions (48.6%) contained only one antibiotic.(10) The current study, like a study conducted by Ravi Pathiyil Shankar et al. (2003), found that the majority of patients were recommended antibiotics for BPI(3). 67% of patients were fully healed by the therapy, 26% of patients showed a controlled response to the therapy, and 7% of patients showed no improvement, according to reports on therapeutic outcomes throughout the hospital stay. Shalem Lakkepogu et al. (2014) conducted a similar study and found that the majority of patients were cured, with only a few individuals failing to respond(3). Streptococcus pneumoniae was the most frequently observed organism in the study, followed by E. coli, Hepatitis A virus, and mycobacterium tuberculosis. This was analogous to the study conducted by Ravi Pathiyil Shankar et al. (2003), who set up that the most constantly insulated species were H.Influenzae, E. coli, K. pnemoniae, and S. aureus. Sputum, urine, blood, tracheal culture, and pus are the instance samples used in this study to assess antibiotic perceptivity patterns.The antibiotic perceptivity pattern was examined, and the results were set up to be analogous to the study conducted by Bijoy Thomas et al (2014) forreporting antibiotic perceptivity patterns exercising urine, trachea, pus, foam, and throat tar.Bijoy Thomas et al. (2014) set up that E.coli is sensitive to Amikacin, which are the Klebsiella, Amikacin, Pseudomonas and Meropenem respectively.(3)

5. Limitation:

There are also a few shortcomings in the current review paper. The cost of DUE treatments was not included in the analysis. This review paper's primary focus was on DUE procedures and techniques, which may limit and differ from other research. Additionally, there has been no mention of any ADR pertaining to DUE in this evaluation. We didn't cover additional metrics like bacterial infections, therapeutic results, or patient care indicators; we just talked about prescription indicators. This review also makes no mention of the pharmacist's role in DUE.

6. CONCLUSION:

The current investigation could evaluate antibiotic prescribing patterns, antibiotic sensitivity patterns, antibiotic side effects, and medication interactions. Cephalosporins were the most often administered antibiotics in the study population, with tetracyclines coming in second. Streptococcus pneumonia was shown to be highly detectable, followed by E. coli, Hepatitis A virus, and Mycobacterium TB, according to the culture sensitivity pattern. The ADRs and Drug interactions were not observed in these studies. By the statistical analysis it was found that the age factor will affect the recovery of the patients. The majority of the patients were cured in these studies. Clinicians and clinical pharmacists must play a key role in reducing antibiotic issues by implementing ongoing education campaigns about the most recent hospital prescription guidelines and reducing antibiotic resistance. For safety and medication monitoring, it is strongly advised that clinical pharmacists actively participate in clinical ward rounds and record their observations on prescriptions in patient folders. Additionally, doctors need to be well-versed in the prudent therapeutic use of antibiotics. They must exercise sound judgment when selecting antibiotic regimens and be aware of the prevalence of various diseases and resistance tendencies in their facility. Irrationality can be combated through guidelines, instructional programs, and observation at all levels of healthcare. As a result, care should be taken to avoid the incorrect use of antibiotics. To evaluate the wise use of antibiotics, a drug use review procedure must be established.

REFERENCES

  1. Govind Naik H, Khanwelkar CC, Kolur A, Desai R, Gidamudi S. National Journal Of Medical Research Drug Utilization Study On Antibiotics Use In Lower Respiratory Tract Infection.
  2. Soltani R, Hakamifard A, Mousavi S, Amani Z. Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital. Vol. 9, J Pharm Care. 2021.
  3. Chitra MB, Pharm M. CERTIFICATE.
  4. Rajini S, Venkateswarulu B. Drug Use Evaluation of Antibiotics In Non-Teaching Tertiary Care Hospital [Internet]. Vol. 1, World Journal of Current. Available from: https://www.wjcmpr.com
  5. Jayakar DB, Aleykutty DNA, Santhosh DR, Mathews M. Evaluation of Oral Antibiotic Utilization In Medical Inpatients.
  6. Rajini S, Venkateswarulu B. Drug Use Evaluation of Antibiotics In Non-Teaching Tertiary Care Hospital [Internet]. Vol. 1, World Journal of Current. Available from: https://www.wjcmpr.com
  7. Thomas AP, Kumar M, Johnson R, More SP, Panda BK. Evaluation of antibiotic consumption and compliance to hospital antibiotic policy in the surgery, orthopedics and gynecology wards of a tertiary care hospital. Clin Epidemiol Glob Health. 2022 Jan 1;13.
  8. Bithi SS, Minhazur M, Khan R, Khan AU. Drug utilization study in orthopaedic units: Antibiotics prescribed in hospital out-patients in Dhaka, Bangladesh [Internet]. Vol. 3, International Current Pharmaceutical Journal. 2014. Available from: http://www.icpjonline.com/documents/Vol3Issue9/01.pdf
  9. Kaur S, Rajagopalan S, Kaur N, Shafiq N, Bhalla A, Pandhi P, et al. Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India. Emerg Med Int. 2014;2014:1–5.
  10. Kala K, Sodhi RK, Jain UK. Drug utilization evaluation of antibiotics in district hospital Rudraprayag. Journal of Drug Delivery and Therapeutics. 2018 Nov 15;8(6):87–90.

Reference

  1. Govind Naik H, Khanwelkar CC, Kolur A, Desai R, Gidamudi S. National Journal Of Medical Research Drug Utilization Study On Antibiotics Use In Lower Respiratory Tract Infection.
  2. Soltani R, Hakamifard A, Mousavi S, Amani Z. Drug Utilization Evaluation of Antibiotics in Intensive Care Units of a Referral Teaching Hospital. Vol. 9, J Pharm Care. 2021.
  3. Chitra MB, Pharm M. CERTIFICATE.
  4. Rajini S, Venkateswarulu B. Drug Use Evaluation of Antibiotics In Non-Teaching Tertiary Care Hospital [Internet]. Vol. 1, World Journal of Current. Available from: https://www.wjcmpr.com
  5. Jayakar DB, Aleykutty DNA, Santhosh DR, Mathews M. Evaluation of Oral Antibiotic Utilization In Medical Inpatients.
  6. Rajini S, Venkateswarulu B. Drug Use Evaluation of Antibiotics In Non-Teaching Tertiary Care Hospital [Internet]. Vol. 1, World Journal of Current. Available from: https://www.wjcmpr.com
  7. Thomas AP, Kumar M, Johnson R, More SP, Panda BK. Evaluation of antibiotic consumption and compliance to hospital antibiotic policy in the surgery, orthopedics and gynecology wards of a tertiary care hospital. Clin Epidemiol Glob Health. 2022 Jan 1;13.
  8. Bithi SS, Minhazur M, Khan R, Khan AU. Drug utilization study in orthopaedic units: Antibiotics prescribed in hospital out-patients in Dhaka, Bangladesh [Internet]. Vol. 3, International Current Pharmaceutical Journal. 2014. Available from: http://www.icpjonline.com/documents/Vol3Issue9/01.pdf
  9. Kaur S, Rajagopalan S, Kaur N, Shafiq N, Bhalla A, Pandhi P, et al. Drug Utilization Study in Medical Emergency Unit of a Tertiary Care Hospital in North India. Emerg Med Int. 2014;2014:1–5.
  10. Kala K, Sodhi RK, Jain UK. Drug utilization evaluation of antibiotics in district hospital Rudraprayag. Journal of Drug Delivery and Therapeutics. 2018 Nov 15;8(6):87–90.

Photo
Rashmitha R.
Corresponding author

Department of pharmacy practice, Krupanidhi College of pharmacy, Carmelaram- 560035, Karnataka, India

Photo
Sahana G.
Co-author

Department of pharmacy practice, Krupanidhi College of pharmacy, Carmelaram- 560035, Karnataka, India

Photo
Beulah Milton
Co-author

Department of pharmacy practice, Krupanidhi College of pharmacy, Carmelaram- 560035, Karnataka, India

Photo
Janavi G.
Co-author

Department of pharmacy practice, Krupanidhi College of pharmacy, Carmelaram- 560035, Karnataka, India

Rashmitha R.*, Beulah Milton., Sahana G., Janavi G., Drug Utilization Evaluation of Antibiotics at A Tertiary Care Hospital, Int. J. of Pharm. Sci., 2025, Vol 3, Issue 6, 253-266. https://doi.org/10.5281/zenodo.15576994

More related articles
Related Articles
Patient’s Satisfaction Towards Outpatient Pharmacy Services At Tertiary Health...
Manjula M. J. , Deepak P. , Sahana G. N., Jayashree V. N., ...
More related articles